[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100444339":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":24,"locations":35,"responsibleParty":63,"collaborators":12,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":67,"sex":73,"minAge":74,"maxAge":12,"enrollmentInfo":75,"targetDuration":12,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":85,"overallStatus":38,"whyStopped":12,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Centre Paul Strauss","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm A Standard of care","NO_INTERVENTION","Patients will receive standard care before treatment initiation (i.e. geriatric assessment only).\n\nGeriatric assessment includes: Mini Mental State Examination ; mini-Geriatric Depression Scale (mini-GDS) ; Body Mass Index (BMI) calculation ; Mini Nutritional Assessment (MNA) ; Time up and Go ; Cumulative Illness Rating Scale - Geriatric (CIRS-G) ; Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) questionnaires.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Arm B Multidisciplinary EPODIG program","EXPERIMENTAL","Patients will undergo the same geriatric assessment as in Arm A plus EPODIG-G program before treatment initiation.",[18],"Other: EPODIG-G program (coordination of supportive care)",[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":12},"EPODIG-G program (coordination of supportive care)","EPODIG-G program includes: a nutritional evaluation (laboratory tests: albumin, pre-albumin, C reactive protein and vitamin D dosage, nutritional status, Handgrip test, Simple Evaluation of Food Intake (SEFI), spontaneous food intake evaluation) ; a medication reconciliation ; physical therapy (Six Minute Walk Test)",[14],[25,31],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"Valérie SARTORI","CONTACT","368767223","33","v.sartori@icans.eu",{"name":32,"role":27,"phone":33,"phoneExt":29,"email":34},"Manon VOEGELIN","368767360","promotion-rc@icans.eu",[36],{"facility":37,"status":38,"city":39,"state":12,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Institut de cancérologie Strasbourg Europe","RECRUITING","Strasbourg","67033","France","FR",{"type":44,"coordinates":45},"Point",[46,47],7.74553,48.58392,{"lat":47,"lon":46},[50,51,53,56,59,61],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},{"name":52,"role":27,"phone":33,"phoneExt":29,"email":34},"Manon VOEGELIN, PhD",{"name":54,"role":55,"phone":12,"phoneExt":12,"email":12},"Meher BEN ABDELGHANI, MD","PRINCIPAL_INVESTIGATOR",{"name":57,"role":58,"phone":12,"phoneExt":12,"email":12},"Damien HEITZ, MD","SUB_INVESTIGATOR",{"name":60,"role":58,"phone":12,"phoneExt":12,"email":12},"Pascale CHIAPPA, MD",{"name":62,"role":58,"phone":12,"phoneExt":12,"email":12},"Virginie LEROY, MD",{"type":64,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100444339","multidisciplinary-evaluation-of-elderly-patients-with-digestive-cancer-epodig-g-100444339",false,"NCT05066139","Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)","Monocentric Randomized Study Evaluating the Impact of an Early Multidisciplinary Program in Elderly Subjects Starting a Chemotherapy for Digestive Cancer: Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)","EPODIG-G","Inclusion Criteria:\n\n* Patients must be ≥ 75 years old\n* Performance status 0, 1 or 2\n* Diagnostic of digestive cancer, all stages (adjuvant or metastatic), with an indication for chemotherapy treatment or targeted therapy for a treatment period of 24 weeks or more\n* Patients previously treated with one or several lines of chemotherapy for this digestive cancer are eligible\n* Estimated life expectancy ≥ 3 months\n* Patients able to speak, read and understand French\n* Signed informed consent from the patient\n* Patients must have a social security coverage\n\nExclusion Criteria:\n\n* History of differentiated neuroendocrine tumors grade 1 or 2 (pancreas, small intestine)\n* Cancer currently being treated (except for hormone therapy) other than current digestive cancer\n* History of major surgery and\u002For curative radiation therapy during the last 4 weeks before inclusion\n* Patients unable to submit to medical follow-up for geographical, social or psychological reasons\n* Patients placed under guardianship","ALL","75 Years",{"count":76,"type":77},144,"ESTIMATED","INTERVENTIONAL",[80],"NA","This is a monocentric, comparative, open-label, randomized parallel group study enrolling elderly subjects hospitalized in Strasbourg Europe Cancerology Institute (ICANS), starting chemotherapy or targeted therapy for the treatment of digestive cancer.",[83,84],"Digestive System Disease","Neoplasms",[86,87,88],"Digestive cancer","supportive care","gastrointestinal cancer","2025-12-30",{"date":91,"type":92},"2026-01-05","ACTUAL",{"date":94,"type":92},"2021-09-17",{"date":96,"type":77},"2030-10-17",{"name":5,"class":6},1]